These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Differentiation of Hepatic Sclerosed Hemangiomas From Cavernous Hemangiomas Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features. Hwang JA, Kang TW, Cha DI, Kim SH, Ha SY, Kim SW. J Comput Assist Tomogr; 2019; 43(5):762-769. PubMed ID: 31356526 [Abstract] [Full Text] [Related]
8. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns. Leslie DF, Johnson CD, Johnson CM, Ilstrup DM, Harmsen WS. AJR Am J Roentgenol; 1995 Mar; 164(3):625-9. PubMed ID: 7863883 [Abstract] [Full Text] [Related]
13. Hepatic cavernous hemangioma: magnetic resonance imaging. Work in progress. Glazer GM, Aisen AM, Francis IR, Gyves JW, Lande I, Adler DD. Radiology; 1985 May; 155(2):417-20. PubMed ID: 3983393 [Abstract] [Full Text] [Related]
14. Hepatic capsular retraction: unusual finding of cavernous hemangioma. Lee SH, Park CM, Cheong IJ, Kwak MS, Cha SH, Choi SY, Kim CH. J Comput Assist Tomogr; 2001 May; 25(2):231-3. PubMed ID: 11242218 [Abstract] [Full Text] [Related]